$AMCR

Amcor plc (AMCR): Results of Operations and Financial Condition

Amcor plc (AMCR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 amcor4q2026ex991-june302026.htm EX-99.1 Document Exhibit 99.1 Amcor Reports Strong Fourth Quarter and Full-Year Results Highlights - Three Months Ended June 30, 2026 • Net sales $6.4 billion, up 26% largely driven by Berry acquisition and pass through of higher raw mate

Original reporting
Published Aug 12, 2026, 10:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 10:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AMCR
Bullish
high confidence
Mentioned
$AMCR
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AMCRBullishHigh
01

Why it matters

Traders can update models using the reported GAAP and adjusted metrics, the stated drivers of sales/EBITDA growth (Berry acquisition, raw-material pass-through, FX), and the explicit transition-period Adjusted EPS range and leverage target.

02

Market read

Fresh earnings and explicit transition guidance (Adjusted EPS $1.80 to $1.90, leverage 3.5x to 3.6x) create a direct catalyst for near-term estimate revisions and positioning.

03

What to watch

Net debt is $12.897B and leverage guidance is still in a tight band, so any integration slippage or cost inflation could quickly pressure the transition-period EPS range.

Relevance 7/10Novelty 9/10Timing: filed pre-market today (2026-08-12) with earnings and transition-period guidance

Background

Amcor filed an SEC 8-K (Item 2.02) with Exhibit 99.1 covering Q4 and full-year results ended June 30, 2026, plus a six-month transition outlook to December 31, 2026.

Company-level read

Ticker impact

$AMCRBullishHigh confidence
Context

Amcor reported Q4 and full-year results with net sales, net income, adjusted EBITDA, and issued a six-month Adjusted EPS outlook for the transition period.

Expected impact

Likely positive near-term bias as the EPS range and leverage guidance support a stronger earnings outlook post-Berry integration.

Evidence & confidence

The 8-K includes specific reported financials (net sales, net income, adjusted EBITDA, FCF) and explicit forward guidance (Adjusted Diluted EPS $1.80 to $1.90, leverage 3.5x to 3.6x) for the next six-month transition period.

Market effects

Consumer packaging and materials peers may see read-across on integration synergy delivery and input-cost pass-through effectiveness.

Limited direct regional impact stated, but dividend timing and FX translation could affect cross-listed holders.

As a global packaging supplier, guidance and synergy progress can influence broader sentiment toward industrial packaging demand and margin resilience.

Counterpoint

The headline strength is heavily influenced by the Berry acquisition and raw-material cost pass-through, so organic demand and underlying margin durability may be less robust than headline growth suggests.

Key entities

  • Amcor plc

    Consumer packaging company reporting Q4 and full-year results and providing transition-period guidance in an SEC 8-K.

  • Berry acquisition

    Acquisition referenced as a major driver of acquired sales/EBIT and synergy realization ahead of plan.

  • Peter Konieczny

    CEO quoted on operating performance, input cost inflation management, and confidence in medium and long-term commitments.

Related articles

$AMCRMed

Amcor Boosts India Output for Healthcare Packaging

Amcor (NYSE: AMCR, ASX: AMC) said it is making a further multi-million-dollar investment in its Sira, Karnataka, India healthcare packaging plant to add a new production line. The company expects higher capacity and shorter lead times for ophthalmic containers and injectable vials, using automated vision systems and more energy-efficient equipment. The facility runs on 100% renewable energy and is ISCC PLUS certified; the expansion will add 30+ jobs.

$AMCRMedAI 8/10

Income Safe-Haven Under $40: Why This Packaging Giant’s 5.8% Yield Is Mispriced

Amcor (AMCR) shares closed at $38.38 on May 22, 2026, with a forward dividend yield of about 5.87%. The company guides for 12% adjusted EPS growth in FY and has raised its dividend 1.96% year over year, paying $0.65 quarterly (next due June 17, 2026). After closing Berry Global’s acquisition on April 30, 2025, Amcor’s consensus price target is $48.21 and Truist reiterated Buy with a $60 target.

$AMCRMedAI 8/10

Is Amcor (AMCR) One of the Top 10 Dividend Aristocrat Stocks Ranked by Yield?

Amcor plc (NYSE:AMCR) is listed among Dividend Aristocrats Ranked by Yield, with an annual dividend yield of 6.62% as of May 29. On May 20, Wells Fargo cut its price target to $41 from $43 and kept an Equal Weight rating, citing merger synergies, leverage reduction, and limited visibility on volume trends. In its fiscal Q3 2026 call, Amcor guided adjusted EPS for 2026 at $3.98–$4.03 and free cash flow at $1.5–$1.6 billion.

$AMCRLowAI 8/10

New Jersey Rep. Tom Kean Jr. ditched Congress for 75 days citing illness. Someone went digging and found out exactly what he's been up to.

New Jersey Rep. Tom Kean Jr. has been absent from Congress for 75 days, citing illness, but records cited by The New Republic and NOTUS say he traveled and traded stocks during the period. He skipped 88 House votes since March 5. NOTUS reports trades in Amcor, Chubb, First Citizens BancShares, Johnson & Johnson, and PepsiCo totaling $50,008–$190,000.

$VECOHighAI 9/10

Veeco’s Q2 results exceed guidance

Veeco Instruments reported Q2 2026 revenue of $193.5m, up 22% sequentially and 16.5% year over year, exceeding $170–190m guidance. Gross margin was 39.5% and operating income $23.1m, above $13–22m guidance. Net income was $21.8m ($0.33/diluted share). Veeco raised full-year 2026 revenue guidance to $780–810m and updated Q3 outlook to $200–220m revenue.